Agenda

CONFERENCE DAY 1
Thursday, 29 November 2018
CONFERENCE DAY 2
Friday, 30 November 2018

Registration and Welcome Coffee in Exhibition Hall

Chairperson’s Opening Remarks

Kazumi Fujikawa, Corporate Officer, Marketing & Business Development, Seed Planning Inc.
Ajai Sulekh, Managing Director and Representative Director, Biogen

Keynote: Value Based Healthcare

Haruhiko Hirate, Corporate Officer, Head of Corporate Affairs and Communication, Takeda

Keynote: Drivers for Improving Japanese Healthcare

Satoru Noguchi, President, Celgene

Networking & Refreshments in Exhibition Hall

Keynote: Challenges and Opportunities for Pharma and Biotech

Yuichi Kubo, Head, Global Brand Strategy, Daiichi Sankyo Co. Ltd.

Keynote: Mega Trends in Healthcare

Rafaat Rahmani, President, Lifescience Dynamics

Networking Luncheon

Keynote: Digital Transformation

Sam Karita, Senior Partner and Managing Director, The Boston Consulting Group

Keynote: How Successful Product Positioning / KOL Management Could Have Been Made in Competitive Landscape

Hiroaki Suzuki, Country Manager, Vetter Pharma

BI case study from extremely busy orphan drug sector experience

Market Landscape

Product situation / position

Market Research activities

Establishment / Implementation of brand re-positioning strategy

Networking & Refreshments in Exhibition Hall

Using Competitive Intelligence to Predict FDA Approval Timelines

Azusa Tanaka, Ph.D., Senior Consultant, Lifescience Dynamics

With the various designations that the FDA grants new therapies, how can we use competitive intelligence (CI) to predict approval timelines?

In this presentation, we will provide:

• Overview of Phase 3 to approval timelines in the USA
• Summary of FDA programs to expedite development of new therapies and how they can impact approval timelines
• How to use competitive intelligence to inform approval timeline

Keynote Summary of the Day, Panel Discussion and Q&A

Kazumi Fujikawa, Corporate Officer, Marketing & Business Development, Seed Planning Inc.
Susumu Misumori, Shionogi
Ajai Sulekh, Managing Director and Representative Director, Biogen

Evening Socializing Events! Cocktail Reception & Networking

Registration and Welcome Coffee in Exhibition Hall

Re-Designing Customer Experience and Innovate Go to Market Model

Ryota Kano, Center of Excellence Integrated Marketing Lead, Pfizer

Pharma industry are facing tremendous cost pressure and stricter regulations, especially role of MR and their activity needs to transform to fit for future environmental shift.

I would like to share my trials and learning about how to re-defining sharing value with our customer and how to engage them by using new technologies.

Generating Actionable Insights

Masaaki (Max) Hattori, Commercial Excellence Head, Merck

Networking & Refreshments in Exhibition Hall

Creating Insights from Promotional & Consumer CI:

Igor Rudychev, Ph.D., Sr. Director of Business Insights, AstraZeneca

1. Major needs in promotional & consumer CI

2. Learning from competitive messaging & promotional programs
3. Improvement of our messaging and promotion
4. Competitive unbranded & branded consumer programs and their impacts
5. Competitive Digital and how to I prove MCM/Digital
6. Competitive ROIs of major promotional programs and impact on sales force sizing
7. Etc.

HCP’s Social Media Tracking

Hanson Zheng, Senior Director, Customer Insight & Innovation, Bristol Myers Squibb

Networking Luncheon

Planning and Launching New Products

Atushito Tomotsugu, Director, Takeda

Role of R&D in Partnering and Strategy

Masahiro Kajita, Associate Director, Eisai

Keynote Summary of the Day, Panel Discussion and Q&A

Kazumi Fujikawa, Corporate Officer, Marketing & Business Development, Seed Planning Inc.
Susumu Misumori, Shionogi
Ajai Sulekh, Managing Director and Representative Director, Biogen

Conference Concludes